Comet Therapeutics
Latest round
- Series A
Last raised
- Jun 2019
Total raised
- $14M
Investors
- 4
About Comet Therapeutics
Comet Therapeutics, Inc.Founded in 2017 and headquartered in Cambridge, US, Comet Therapeutics, Inc. specializes in creating therapeutics targeting specific biological pathways.Comet Therapeutics specializes in developing innovative therapeutics aimed at addressing unmet medical needs in various therapeutic areas. The company’s core product offerings include advanced biopharmaceuticals designed to target specific biological pathways implicated in chronic diseases, particularly focusing on autoimmune disorders and metabolic diseases.Comet Therapeutics generates revenue through strategic partnerships and collaborations with other pharmaceutical entities, along with direct sales of its proprietary therapeutics.The most recent deal, finalized on August 31, 2021, involved the acquisition of Comet Therapeutics, Inc. by Vectivbio AG, which aims to enhance its rare disease pipeline.
Who invested in Comet Therapeutics
4 investors across 2 rounds
See all investors in Comet Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Comet Therapeutics
Who invested in Comet Therapeutics?
Comet Therapeutics has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Comet Therapeutics raised?
Comet Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Comet Therapeutics last raise money?
Comet Therapeutics's most recent round on record is a Series A, in Jun 2019.
What does Comet Therapeutics do?
Comet Therapeutics is a biopolymers company.
Where is Comet Therapeutics headquartered?
Comet Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Comet Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biopolymers companies at Comet Therapeutics's stage. Their profiles are linked below.
VCs backing biopolymers startups at Series A
Raising like Comet Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.